Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net earnings before noncontrolling interests	$ 2,319	$ 4,913	$ 8,079
Adjustments:
Depreciation	1,094	931	827
Amortization	262	238	235
Stock-based compensation	132	130	137
Deferred income taxes	(116)	21	(47)
Distributions from affiliates	25	34	57
Equity in earnings of unconsolidated affiliates	(30)	(13)	(11)
Losses and impairments of assets	137		102
Changes in assets and liabilities (exclusive of acquisitions and dispositions):
Accounts receivable	319	664	501
Inventories	518	(75)	962
Accounts payable	(321)	361	(496)
Federal income taxes	97	188	(337)
Salaries, wages and related accruals	(385)	(291)	155
Other operating activities	(72)	11	(92)
Cash provided by operating activities	3,979	7,112	10,072
Investing activities:
Capital expenditures	(3,173)	(2,214)	(1,948)
Investment in and advances to affiliates		(35)
Sale of business	1		100
Disposition of plant and equipment	17	15	32
Acquisitions (net of cash acquired)	(758)	(71)	(3,553)
Purchases of investments	(1,296)	(1,472)	(914)
Proceeds from the sale of investments	1,487	1,317	590
Other investing activities	(12)	(36)	(10)
Cash used in investing activities	(3,734)	(2,496)	(5,703)
Financing activities:
Net change in short-term debt	105	(25)	(59)
Proceeds from issuance of long-term debt, net of discount			2,092
Repayment of long-term debt	(10)	(10)	(1,111)
Bond issuance costs			(13)
Proceeds from exercise of stock options	4	12	23
Payment of tax withholdings on certain stock-based compensation	(53)	(49)	(64)
Distributions to noncontrolling interests	(352)	(435)	(332)
Cash dividends	(522)	(515)	(534)
Acquisition of treasury stock	(2,217)	(1,554)	(2,763)
Proceeds from government incentives			275
Other financing activities	(13)	(17)	(25)
Cash used in financing activities	(3,058)	(2,593)	(2,511)
Effect of exchange rate changes on cash	(16)	3	(6)
(Decrease) increase in cash and cash equivalents and restricted cash and cash equivalents	(2,829)	2,026	1,852
Cash and cash equivalents and restricted cash and cash equivalents - beginning of year	6,387	4,361	2,509
Cash and cash equivalents and restricted cash and cash equivalents - end of year	3,558	6,387	4,361
Non-cash investing activity:
Change in accrued plant and equipment purchases	$ 115	$ 1	$ 5